Efficacy and Safety Data from Phase 2B Trials of Janssen's Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Live... (investigational nucleotide analogue poly...)

HOME >> MEDICINE >> TECHNOLOGY

Efficacy and Safety Data from Phase 2B Trials of Janssen's Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases

Date:11/10/2012

investigational nucleotide analogue polymerase inhibitor VX-135 for the treatment of HCV. As a first step, Janssen will conduct a drug-drug interaction (DDI) study with simeprevir and VX-135.

For additional information about simeprevir, please visit www.clinicaltrials.gov.

About Hepatitis C
Hepatitis C, a blood-borne infectious disease of the liver and a leading cause of chronic liver disease and liver transplants, is a rapidly evolving treatment area with a clear need for innovative treatments. Approximately 170 to 210 million people are infected with hepatitis C worldwide, with three to four million people newly infected each year.

About Janssen
At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in infectious diseases and vaccines, oncology, immunology, neuroscience, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Janssen Pharmaceuticals, Inc. is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssenrnd.com for more information.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Janssen Pharmaceuticals, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and curr
'/>"/>

SOURCE Janssen Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. JAMA Study Demonstrates Efficacy of Life Technologies Lung Cancer Test in Detecting Early Metastases, Supports Screening for Lung Cancer
2. Optimization of Comparative Efficacy Trials
3. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
4. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
5. MedQIA unique CAD algorithm for Quantitation of lung involvement in diffuse lung disease used as treatment efficacy end point in study to be reported at the ERS Annual Conference in Vienna, Austria: September 1-5, 2012
6. Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis
7. FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
8. Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study
9. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
10. Compounding Pharmacy Safety: Dr. Paul Savage Published in IMJC Post #Meningitis Outbreak
11. Kansas Car Umbrella Encouraged By New Safety Report

Post Your Comments:

(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...

(Date:5/23/2013)... MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...

(Date:5/23/2013)... 2013 The need to add tissue preserving ... highlighted prominently at the 108 th Annual ... San Diego. According to SonaCare Medical, a leader ... technology, the need for image-guided technologies to better ... consider minimally invasive ablative treatments, was addressed in ...

Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6

[0] Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference [0] MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 [0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting

... CSL Behring has been informed by the U.S. Food ... first FDA-approved treatment of acute bleeding episodes in patients ... seven years of orphan-drug exclusivity. RiaSTAP was approved ... the treatment of acute bleeding episodes in patients with ...

... Medicated Arthri-Zen Relief Cream(R) Clinically Shown to Work for up ... Americans suffer from the aches and pains that come with ... effective ways to get fast relief from arthritis pain is ... the relief tends to be short-lived. Many people find that ...

Cached Medicine Technology:CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency 2 CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency 3 CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency 4 Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain 2 Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain 3

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain

(Date:5/25/2013)... MA (PRWEB) May 25, 2013 Imagine running ... -- the energy loss, hot air and wasted energy! If ... house fan, a fireplace or clothes dryer, that may be ... Drafts from these often overlooked holes waste energy in the ... of heating and cooling loss in the home. , Drafts ...

(Date:5/25/2013)... 25, 2013 Dr. Leslie Gerstman ... FDA-approved to lift skin on the neck, on the brow ... practice, Medical Aesthetics. , Ultherapy is a non-surgical procedure for ... healing process to lift the skin over time. The use ... to see and then treat the deepest support layers of ...

(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...

(Date:5/25/2013)... and parasites that affect both dogs and humans, such ... can result in liver or kidney failure -- may ... These germs could be found in the ... Nelson, a clinical associate professor at Kansas State University,s ... be fatal, even with treatment," she said in a ...

(Date:5/25/2013)... United States (PRWEB) May 25, 2013 ... and largest underground shelter company in the US ... composite underground structures for over 35 years. M.E. ... PROTECTION, U.S. Handbook of NBC Weapon Fundamentals and ... the United States’ bible on shelter engineering. McCarthy ...

Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2 Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3 Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4 Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2 Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2 Health News:Hidden Dangers Dog Dog Parks 2 Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2 Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3

[0] How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation [0] Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ [0] Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas [0] Hidden Dangers Dog Dog Parks [0] Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster

... to be Featured on Yahoo! Answers -, The Partnership Joins Dr. ... ... Abuse Treatment, NEW YORK, Jan. 9 The Partnership for a ... "Celebrity Rehab With Dr. Drew," is helping support the,Partnership,s new cause marketing ...

... fuel debate about screening for cardiovascular problems , , WEDNESDAY, ... identified an abnormal heartbeat pattern in young athletes that ... later in life. , The report comes amid intense ... potential cardiac problems, said Dr. Mark S. Link, director ...

... only been a few weeks since you made that New Years ... days maybe even weeks. , You know all the ... which would obviously be nice, exercise has been linked to reduced ... of sitting on the couch and watching TV instead of going ...

... Texas Mutual Insurance Company, an,aggressive tort reform advocate in ... litigation in which the insurance company tried,to overturn an ... a workplace injury,a Dallas state district judge ruled today., ... medical record,Texas Mutual had no evidence to continue to ...

... N.J., Jan. 9 Managed Health Care,Associates, Inc. ... the addition of two outside members, Mr. Barry ... Board of Directors. Mr. Freedman and Mr.,Wheelan join ... Diamond Castle Holdings, LLC., Barry Freedman is ...

... AlphaRx (OTC BB:ALRX -,News) stated on Tuesday that CEO ... in the open market, bringing the total number of,shares ... his,continued confidence in the Company,s future., Mr. Michael ... for,an average price of $0.24 each, increasing his holdings ...

Dr. Drew Joins the Partnership for a Drug-Free America in Supporting TimeToTalk(TM)Test Finds Rare Heart Defect in Some Young Athletes Exercising judgment: The psychology of fitness Judge Rules Texas Mutual Insurance Co. Committed Litigation Fraud With Falsified Document, According to Doyle Raizner LLP MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors AlphaRx CEO Accumulates More Company Shares

... TL-3000B Auto Lensmeter is designed for fast & ... makes it easier to operate for everyone., ,In ... the lens is properly aligned. Multi-Focal lenses are ... you to correctly position the lens. The color ...

... takes the guesswork out of measuring progressive ... It allows you to read two lenses ... you read them, automatically read prism, and ... TL-100 changes automatically from single vision mode ...

... The Kowa RC-XV3 camera is ... The automatic exposure system, ... sensitivity, the 2.5~300ws watt indication ... handling are the basic features ...

FF 450plus fundus camera for 35mm photography. Upgradeable basic instrument for brilliant image quality....

Medicine Products:

TL-3000B Auto Lensemeter TL-100 Auto Lensemeter KOWA nonmyd 7 / VK-2 Digital Imaging System FF 450^plus Fundus Camera